SAB Biotherapeutics
SABS
SABS
24 hedge funds and large institutions have $15.2M invested in SAB Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 21 closing their positions.
Holders
24
Holders Change
-18
Holders Change %
-42.86%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
12
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$801K |
2 |
2
Millennium Management
New York
|
$245K |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$288K |
4 |
4
BlackRock
New York
|
$28.8K |
5 |
![]()
5
Marshall Wace
London,
United Kingdom
|
$2.08M |